Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects With Disability Following an Ischemic Stroke

NCT03629275 is registered in ClinicalTrials.gov with ReNeuron Limited as lead sponsor.

NCT NCT03629275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03629275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects With Disability Following an Ischemic Stroke
Lead sponsor
ReNeuron Limited
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2018
Completion date
March 2, 2021
Enrollment
15 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

arm paralysis, chronic stroke, hemiparesis, ischemic stroke